A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Phase 1 other active
Quick answer
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma for Advanced or Metastatic Hepatocellular Carcinoma is a Phase 1 program (other) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Advanced or Metastatic Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- other
- Status
- active